Hidemasa Ogawa

948 total citations
56 papers, 752 citations indexed

About

Hidemasa Ogawa is a scholar working on Endocrinology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Hidemasa Ogawa has authored 56 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, 15 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Hidemasa Ogawa's work include Escherichia coli research studies (19 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). Hidemasa Ogawa is often cited by papers focused on Escherichia coli research studies (19 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Viral gastroenteritis research and epidemiology (7 papers). Hidemasa Ogawa collaborates with scholars based in Japan and Armenia. Hidemasa Ogawa's co-authors include Akiko Nakamura, Rintaro NAKAYA, Yasushi Abiko, Riichi Sakazaki, Y Osada, Shigeo Honjo, MASAO TAKASAKA, Kiyoshi Imaizumi, Tooru Fujiwara and Tsutomu Une and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Microbiology.

In The Last Decade

Hidemasa Ogawa

55 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidemasa Ogawa Japan 17 269 207 126 98 96 56 752
R. J. Jones United Kingdom 17 173 0.6× 108 0.5× 309 2.5× 265 2.7× 63 0.7× 45 1.1k
M R Islam Bangladesh 15 280 1.0× 146 0.7× 101 0.8× 74 0.8× 109 1.1× 26 639
Mysan Le United States 11 205 0.8× 210 1.0× 212 1.7× 179 1.8× 278 2.9× 15 1.0k
S. N. De India 9 614 2.3× 198 1.0× 159 1.3× 47 0.5× 209 2.2× 18 930
H Finger Germany 17 127 0.5× 140 0.7× 236 1.9× 222 2.3× 145 1.5× 138 1.0k
Ivan Kochan United States 13 68 0.3× 174 0.8× 117 0.9× 116 1.2× 59 0.6× 26 593
N L King-Thompson United States 12 84 0.3× 190 0.9× 157 1.2× 232 2.4× 30 0.3× 15 854
Mi‐Jurng Kim Australia 14 221 0.8× 98 0.5× 331 2.6× 104 1.1× 68 0.7× 14 1.1k
R. Lissner Germany 14 101 0.4× 243 1.2× 86 0.7× 69 0.7× 37 0.4× 46 659
Santanu Chattopadhyay India 19 101 0.4× 133 0.6× 157 1.2× 159 1.6× 69 0.7× 45 1.0k

Countries citing papers authored by Hidemasa Ogawa

Since Specialization
Citations

This map shows the geographic impact of Hidemasa Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidemasa Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidemasa Ogawa more than expected).

Fields of papers citing papers by Hidemasa Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidemasa Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidemasa Ogawa. The network helps show where Hidemasa Ogawa may publish in the future.

Co-authorship network of co-authors of Hidemasa Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hidemasa Ogawa. A scholar is included among the top collaborators of Hidemasa Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidemasa Ogawa. Hidemasa Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hara, Tsuyoshi, Masahiro Iwamoto, Hidemasa Ogawa, Asako Yamamoto, & Munehiro Tomikawa. (1990). Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061). Thrombosis Research. 59(4). 703–712. 3 indexed citations
2.
Sato, Keiki, et al.. (1986). Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.. PubMed. 77(2). 212–8. 3 indexed citations
3.
Sato, Keiki, et al.. (1985). PREPARATION OF MONOCLONAL ANTIBODY TO HEPATOCELLULAR MEMBRANES AND ITS APPLICATION TO INDUCTION OF LIVER CELL MEMBRANE DAMAGE. Acta Pathologica Japonica. 35(6). 1375–1383. 7 indexed citations
4.
Nakajima, Hiroto, et al.. (1984). Host-mediated antitumor effect of DMG, a degraded D-manno-D-glucan from Microellobosporia grisea culture fluid.. PubMed. 75(3). 253–9. 8 indexed citations
5.
Tanaka, Noriko, et al.. (1983). Effects of human fibroblast interferon on human gliomas transplanted into nude mice.. PubMed. 74(2). 308–16. 21 indexed citations
6.
Osada, Y, Masao Mitsuyama, Kensuke Matsumoto, et al.. (1982). Stimulation of Resistance of Immunocompromised Mice by a Muramyl Dipeptide Analog. Infection and Immunity. 37(3). 1285–1288. 22 indexed citations
7.
Tanaka, Noriko, Tsutomu Une, & Hidemasa Ogawa. (1981). EXPERIMENTAL PYELONEPHRITIS IN MICE FOLLOWING ASCENDING INFECTION WITH E. COLI. Acta Pathologica Japonica. 31(2). 189–198. 2 indexed citations
8.
Kumada, Toshihiko, et al.. (1980). Experimental model of venous thrombosis in rats and effect of some agents. Thrombosis Research. 18(1-2). 189–203. 37 indexed citations
9.
NAKAYA, Rintaro, Noboru Okamura, Hidemasa Ogawa, & Y Osada. (1977). . Nippon Saikingaku Zasshi. 32(6). 785–804. 1 indexed citations
10.
Osada, Y, et al.. (1975). Divalent Cation Stimulation of the Cell Infectivity ofShigella flexneri2a. Japanese Journal of Microbiology. 19(2). 163–166. 10 indexed citations
11.
Osada, Y, Tsutomu Une, Masayuki Nakajo, & Hidemasa Ogawa. (1973). Virulence of Rifampicin‐Resistant Mutants ofShigellaand EnteropathogenicEscherichia coliwith Special Reference to Their Cell Invasiveness. Japanese Journal of Microbiology. 17(4). 243–249. 3 indexed citations
12.
Osada, Y, Tsutomu Une, & Hidemasa Ogawa. (1973). Inhibition of Cell to Cell Transfer ofShigellaby Treatment with Some Antibiotics. Japanese Journal of Microbiology. 17(3). 233–235. 1 indexed citations
13.
Osada, Y, Masayuki Nakajo, Tsutomu Une, Hidemasa Ogawa, & Yasuo Oshima. (1972). Application of Cell Culture in Studying Antibacterial Activity of Rifampicin toShigellaand EnteropathogenicEscherichia coli. Japanese Journal of Microbiology. 16(6). 525–533. 12 indexed citations
14.
Osada, Y, Masayuki Nakajo, & Hidemasa Ogawa. (1972). Application of Experimental Keratoconjunctivitis Shigellosa in Chemotherapeutic Evaluation of Rifampicin to Bacillary Dysentery. Japanese Journal of Microbiology. 16(4). 329–332. 7 indexed citations
15.
Osada, Y, Masayuki Nakajo, & Hidemasa Ogawa. (1971). Experimental Urinary Infection in Guinea Pigs. Nippon Saikingaku Zasshi. 26(11). 553–562. 1 indexed citations
16.
TAKASAKA, MASAO, Shigeo Honjo, Kiyoshi Imaizumi, & Hidemasa Ogawa. (1970). DYSENTERY PRODUCED BY ORAL ADMINISTRATION OF THE COLONIC CONTENTS OF CYNOMOLGUS MONKEYS INFECTED WITH SHIGELLA FLEXNERI 2a. Japanese Journal of Medical Science and Biology. 23(4). 249–254. 3 indexed citations
18.
Ogawa, Hidemasa, Akiko Nakamura, & Riichi Sakazaki. (1968). PATHOGENIC PROPERTIES OF ^|^ldquo;ENTEROPATHOGENIC^|^rdquo; ESCHERICHIA COLI FROM DIARRHEAL CHILDREN AND ADULTS. Japanese Journal of Medical Science and Biology. 21(5). 333–349. 35 indexed citations
19.
Ogawa, Hidemasa, Akiko Nakamura, & Rintaro NAKAYA. (1968). CINEMICROGRAPHIC STUDY OF TISSUE CELL CULTURES INFECTED WITH SHIGELLA FLEXNERI. Japanese Journal of Medical Science and Biology. 21(4). 259–273. 71 indexed citations
20.
TAKASAKA, MASAO, Shigeo Honjo, Tooru Fujiwara, et al.. (1968). SHIGELLOSIS IN CYNOMOLGUS MONKEYS (MACACA IRUS). Japanese Journal of Medical Science and Biology. 21(4). 275–281. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026